Longitudinal Biomarker of Alzheimer's Disease
common.study.values.description
“Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study”
This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This future research will also study how treatments for these diseases work. This research may help develop new treatments for some diseases of the nervous system and help understand these diseases better.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
common.study.methods.no-methods
participant.views.study.view.additional
participant.views.study.view.scientific-title
Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study
common.study.values.clinical-trial-id
NCT02612376
participant.views.study.view.id
neg8Da
